Short selling involves borrowing shares and then selling them at current market prices. In the successful version of the ...
In my talks on innovation and simplification, I pose a simple question to my audiences: "How many of you wish you had more ...
This summary covers recent significant events in the health sector, including major deals, court decisions, new drug ...
The U.S. Food and Drug Administration has approved Merus NV's therapy that targets a particular gene, expanding treatment ...
Green roofs are celebrated for their environmental and financial benefits. Commonplace in Germany, they are slowly growing on ...
Monte Rosa Therapeutics stock surged after a recent partnership with Novartis, despite limited clinical results. Can the ...
Oppenheimer analysts, led by Jay Olson, said the data support development in earlier-line settings, "and its three-month performance strengthens our optimism surrounding longer-term MMR data," which ...
The U.S. Court of Appeals has reportedly ruled against Novartis (NVS) in its bid to prevent the U.S. launch of a generic ...
We recently compiled a list of the 10 Best Small-Cap Biotech Stocks with Massive Potential According to Hedge Funds. In this ...
In a meta-analysis of 57 studies, Zolgensma achieved a 95% survival rate and reduced the number of patients requiring ...
European stocks advanced for a fifth consecutive session as German shares hit a fresh record. Investors were watching the ...
Novartis failed to convince a U.S. appeals court on Wednesday to halt MSN Pharmaceuticals' proposed generic of Novartis' ...